Top news of the week: 29.12.2020.
Companies And Industries
Biopharma deals at their height; 2020 hard to beat
With record financings and now record deals in 2020, as well as a respectable value accumulated through completed mergers and acquisitions, the biopharma industry has managed to circumvent ...
Looking ahead to 2021: Hope for life beyond COVID-19 but shaped by the pandemic
The global pandemic has put the spotlight on the life science industry, and, for the most part, it has stood up to the intensity of its glare.
Fierce Biotech's Top 10 stories of 2020—COVID, COVID and more COVID
“Lockdown” has been named the Collins Word of the Year 2020. At Fierce Biotech, the word our team has been writing the most is, in fact, not even a word, but an abbreviation: COVID-19.
Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program
Japanese pharma Astellas and its new biotech buyout Audentes got a Christmas gift from the FDA when the agency lifted the clinical hold on its gene therapy. The agency slapped a hold on the ...
With FDA nod, Ridgeback's Ebanga joins Regeneron's Inmazeb in the Ebola-fighting arsenal
Nearly seven years after the largest-ever Ebola epidemic broke out in West Africa, two drugs against the deadly virus are now available. The FDA approved Ridgeback Biotherapeutics’ Ebanga ...
2021 forecast: Targeted delivery, oral vaccines and mRNA 2.0: The next generation of drugs and prophylactics in the fight against COVID-19
As the chapter closes on the first year of the COVID-19 pandemic, drugmakers are hard at work bolstering the defenses mounted in 2020—and they're looking at new formulations and delivery ...
Regulatory Leadership in the Time of COVID-19 and Beyond
Earlier this year, DIA held its first Regulatory Affairs Leadership Forum as part of DIA Europe 2020.
OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test
OTTAWA, Dec. 23, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection...